Similar articles

• Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.

  Dew JE, Wren BG, Eden JA. Dew JE, et al. Climacteric. 2002 Jun;5(2):151-5. Climacteric. 2002. PMID: 12051110
• Chemoprevention of breast cancer for women at high risk.

  Chan K, Morris GJ. Chan K, et al. Semin Oncol. 2006 Dec;33(6):642-6. doi: 10.1053/j.seminoncol.2006.08.017. Semin Oncol. 2006. PMID: 17145342 Review.
• Design of an ideal hormone replacement therapy for women.

  Tonetti DA, Jordan VC. Tonetti DA, et al. Mol Carcinog. 1996 Nov;17(3):108-11. doi: 10.1002/(SICI)1098-2744(199611)17:3<108::AID-MC1>3.0.CO;2-B. Mol Carcinog. 1996. PMID: 8944069 Review. No abstract available.
• Chemoprevention of breast cancer.

  Dalton RR, Kallab AM. Dalton RR, et al. South Med J. 2001 Jan;94(1):7-15. South Med J. 2001. PMID: 11213947 Review.
• Seven for 2007: seven things you should know about breast cancer risk. There's no big way to reduce your risk for breast cancer, but a combination of approaches could make a difference.

  [No authors listed] [No authors listed] Harv Womens Health Watch. 2007 Jan;14(5):1-3. Harv Womens Health Watch. 2007. PMID: 17304697 No abstract available.